TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Ilpinab AB
Closing information (x1000 EUR)
Closing information | 2024/12 | 2023/12 | 2022/12 |
Turnover |
264
|
246 | |
Financial expenses |
0
![]() |
0 | |
Earnings before taxes |
81
|
68 | |
EBITDA |
81
|
69 | |
Total assets |
129
|
135 | |
Current assets |
128
|
133 | |
Current liabilities |
46
|
62 | |
Equity capital |
83
|
73 | |
- share capital |
5
|
4 | |
Employees (average) |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Solvency |
64.3%
|
54.1% | |
Turnover per employee |
88
|
82 | |
Profit as a percentage of turnover |
30.7%
|
27.6% | |
Return on assets (ROA) |
62.8%
|
50.4% | |
Current ratio |
278.3%
|
214.5% | |
Return on equity (ROE) |
97.6%
|
93.2% | |
Change turnover |
17
|
140 | |
Change turnover % |
11%
|
7%
|
132% |
Chg. No. of employees |
0
![]() |
0
|
1 |
Chg. No. of employees % |
0%
![]() |
0%
|
50% |
Total value of public sale
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.